| 4/21/2026 | Weiss Ratings | Reiterated Rating | Sell (E+) ➝ Sell (E+) | | |
| 4/21/2026 | Barclays | Lower Target | Overweight ➝ Overweight | $9.00 ➝ $8.00 | |
| 3/2/2026 | The Goldman Sachs Group | Lower Target | Neutral ➝ Neutral | $13.00 ➝ $8.00 | |
| 2/27/2026 | KeyCorp | Lower Target | Underweight ➝ Underweight | $9.00 ➝ $6.00 | |
| 2/27/2026 | Needham & Company LLC | Lower Target | Buy ➝ Buy | $32.00 ➝ $14.00 | |
| 2/27/2026 | Canaccord Genuity Group | Reiterated Rating | Buy ➝ Hold | $16.00 ➝ $9.00 | |
| 2/3/2026 | Jefferies Financial Group | Lower Target | Buy ➝ Buy | $15.00 ➝ $12.00 | |
| 1/22/2026 | Weiss Ratings | Reiterated Rating | Sell (E+) ➝ Sell (E+) | | |
| 1/12/2026 | Barclays | Lower Target | Overweight ➝ Overweight | $26.00 ➝ $13.00 | |
| 11/13/2025 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $17.00 ➝ $14.00 | |
| 11/7/2025 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $25.00 ➝ $16.00 | |
| 10/8/2025 | Weiss Ratings | Reiterated Rating | Sell (E+) ➝ Sell (E+) | | |
| 9/27/2025 | Weiss Ratings | Reiterated Rating | Sell (E+) ➝ Sell (E+) | | |
| 8/13/2025 | Zacks Research | Downgrade | Strong-Buy ➝ Hold | | |
| 8/7/2025 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $30.00 ➝ $25.00 | |
| 8/7/2025 | The Goldman Sachs Group | Lower Target | Neutral ➝ Neutral | $24.00 ➝ $21.00 | |
| 8/7/2025 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $32.00 ➝ $23.00 | |
| 6/3/2025 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Neutral | $24.00 | |
| 5/28/2025 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $32.00 | |
| 5/9/2025 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $38.00 ➝ $32.00 | |
| 4/21/2025 | Barclays | Lower Target | Overweight ➝ Overweight | $34.00 ➝ $26.00 | |
| 4/17/2025 | The Goldman Sachs Group | Lower Target | Neutral ➝ Neutral | $29.00 ➝ $23.00 | |
| 4/16/2025 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $30.00 ➝ $22.00 | |
| 2/27/2025 | Scotiabank | Lower Target | Sector Perform ➝ Sector Perform | $28.00 ➝ $25.00 | |
| 2/26/2025 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $40.00 ➝ $35.00 | |
| 2/26/2025 | The Goldman Sachs Group | Lower Target | Neutral ➝ Neutral | $34.00 ➝ $29.00 | |
| 2/26/2025 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $37.00 ➝ $30.00 | |
| 2/26/2025 | Stifel Nicolaus | Lower Target | Buy ➝ Buy | $45.00 ➝ $34.00 | |
| 2/26/2025 | Needham & Company LLC | Lower Target | Buy ➝ Buy | $55.00 ➝ $32.00 | |
| 2/26/2025 | Piper Sandler | Lower Target | Neutral ➝ Neutral | $29.00 ➝ $27.00 | |
| 2/26/2025 | Barclays | Lower Target | Overweight ➝ Overweight | $38.00 ➝ $34.00 | |
| 2/3/2025 | Jefferies Financial Group | Boost Target | Buy ➝ Buy | $34.00 ➝ $42.00 | |
| 1/15/2025 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $55.00 ➝ $55.00 | |
| 1/13/2025 | Morgan Stanley | Boost Target | Equal Weight ➝ Equal Weight | $36.00 ➝ $37.00 | |
| 12/3/2024 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $40.00 ➝ $38.00 | |
| 11/18/2024 | Scotiabank | Initiated Coverage | Sector Perform | $28.00 | |
| 11/11/2024 | Piper Sandler | Lower Target | Neutral ➝ Neutral | $40.00 ➝ $29.00 | |
| 11/8/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $55.00 ➝ $55.00 | |
| 10/24/2024 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $43.00 ➝ $40.00 | |
| 10/11/2024 | Barclays | Lower Target | Overweight ➝ Overweight | $48.00 ➝ $38.00 | |
| 8/22/2024 | KeyCorp | Downgrade | Sector Weight ➝ Underweight | $28.00 | |
| 8/2/2024 | Robert W. Baird | Boost Target | Neutral ➝ Neutral | $38.00 ➝ $40.00 | |
| 8/2/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $46.00 ➝ $46.00 | |
| 8/2/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $55.00 ➝ $55.00 | |
| 7/24/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $55.00 ➝ $55.00 | |
| 7/16/2024 | Barclays | Lower Target | Overweight ➝ Overweight | $50.00 ➝ $48.00 | |
| 6/27/2024 | Robert W. Baird | Lower Target | Neutral ➝ Neutral | $45.00 ➝ $38.00 | |
| 6/7/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $55.00 ➝ $55.00 | |
| 5/16/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $55.00 | |
| 5/3/2024 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $70.00 ➝ $50.00 | |
| 5/3/2024 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $65.00 ➝ $49.00 | |
| 5/3/2024 | William Blair | Reiterated Rating | Outperform ➝ Market Perform | | |
| 5/3/2024 | Barclays | Lower Target | Overweight ➝ Overweight | $72.00 ➝ $50.00 | |
| 5/3/2024 | Cantor Fitzgerald | Lower Target | Overweight ➝ Overweight | $74.00 ➝ $46.00 | |
| 5/3/2024 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $76.00 ➝ $43.00 | |
| 5/3/2024 | The Goldman Sachs Group | Downgrade | Buy ➝ Neutral | $80.00 ➝ $44.00 | |
| 5/3/2024 | Needham & Company LLC | Lower Target | Buy ➝ Buy | $75.00 ➝ $55.00 | |
| 5/3/2024 | KeyCorp | Downgrade | Overweight ➝ Sector Weight | | |
| 5/3/2024 | Robert W. Baird | Downgrade | Outperform ➝ Neutral | $72.00 ➝ $45.00 | |
| 5/3/2024 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $66.00 ➝ $40.00 | |
| 5/3/2024 | BTIG Research | Downgrade | Buy ➝ Neutral | | |
| 4/22/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $75.00 | |
| 4/18/2024 | Oppenheimer | Initiated Coverage | Outperform | $76.00 | |
| 4/17/2024 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $73.00 ➝ $65.00 | |
| 4/16/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $75.00 | |
| 3/21/2024 | KeyCorp | Initiated Coverage | Overweight | $83.00 | |
| 2/21/2024 | Barclays | Lower Target | Overweight ➝ Overweight | $75.00 ➝ $72.00 | |
| 2/21/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $74.00 | |
| 2/21/2024 | Canaccord Genuity Group | Reiterated Rating | Buy ➝ Buy | $70.00 | |
| 2/21/2024 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $62.00 ➝ $66.00 | |
| 2/21/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $75.00 | |
| 2/7/2024 | Jefferies Financial Group | Initiated Coverage | Buy | $76.00 | |
| 1/23/2024 | The Goldman Sachs Group | Boost Target | Buy ➝ Buy | $65.00 ➝ $81.00 | |
| 1/19/2024 | Stifel Nicolaus | Boost Target | Buy ➝ Buy | $60.00 ➝ $70.00 | |
| 1/19/2024 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $75.00 | |
| 1/12/2024 | Barclays | Boost Target | Overweight ➝ Overweight | $65.00 ➝ $75.00 | |
| 1/2/2024 | Cantor Fitzgerald | Upgrade | Neutral ➝ Overweight | $48.00 ➝ $74.00 | |
| 11/3/2023 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $56.00 ➝ $62.00 | |
| 10/23/2023 | KeyCorp | Lower Target | Overweight ➝ Overweight | $62.00 ➝ $58.00 | |
| 10/10/2023 | Stephens | Initiated Coverage | Overweight | $78.00 | |
| 9/28/2023 | Piper Sandler | Reiterated Rating | Overweight ➝ Overweight | $56.00 | |
| 9/28/2023 | Cantor Fitzgerald | Boost Target | Neutral ➝ Neutral | $44.00 ➝ $48.00 | |
| 9/15/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $75.00 | |
| 8/7/2023 | Morgan Stanley | Boost Target | Equal Weight ➝ Equal Weight | $52.00 ➝ $55.00 | |
| 8/7/2023 | Piper Sandler | Reiterated Rating | Overweight ➝ Overweight | $56.00 | |
| 8/6/2023 | BTIG Research | Lower Target | | $76.00 ➝ $70.00 | |
| 8/4/2023 | Cantor Fitzgerald | Lower Target | | $46.00 ➝ $44.00 | |
| 8/4/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $75.00 | |
| 8/2/2023 | KeyCorp | Boost Target | Overweight ➝ Overweight | $58.00 ➝ $67.00 | |
| 7/6/2023 | The Goldman Sachs Group | Initiated Coverage | Buy | $61.00 | |
| 5/3/2023 | Stifel Nicolaus | Lower Target | | $75.00 ➝ $60.00 | |
| 5/3/2023 | BTIG Research | Lower Target | | $100.00 ➝ $76.00 | |
| 5/3/2023 | Piper Sandler | Lower Target | | $78.00 ➝ $56.00 | |
| 5/3/2023 | Cantor Fitzgerald | Lower Target | | $52.00 ➝ $46.00 | |
| 5/3/2023 | Robert W. Baird | Lower Target | | $78.00 ➝ $60.00 | |
| 5/3/2023 | Barclays | Lower Target | | $72.00 ➝ $62.00 | |
| 4/6/2023 | Piper Sandler | Reiterated Rating | Overweight | $78.00 | |
| 2/22/2023 | Canaccord Genuity Group | Boost Target | Buy | $65.00 ➝ $70.00 | |
| 2/22/2023 | Piper Sandler | Boost Target | Overweight | $70.00 ➝ $78.00 | |
| 2/22/2023 | Needham & Company LLC | Reiterated Rating | Buy | $75.00 | |
| 2/22/2023 | Barclays | Boost Target | Overweight | $63.00 ➝ $72.00 | |
| 2/13/2023 | Cantor Fitzgerald | Downgrade | Overweight ➝ Neutral | $62.00 ➝ $53.00 | |
| 1/18/2023 | KeyCorp | Boost Target | Overweight | $60.00 ➝ $75.00 | |
| 12/13/2022 | Morgan Stanley | Boost Target | Equal Weight | $60.00 ➝ $63.00 | |
| 11/17/2022 | Robert W. Baird | Boost Target | Outperform | $64.00 ➝ $76.00 | |
| 11/4/2022 | Morgan Stanley | Lower Target | Equal Weight | $66.00 ➝ $60.00 | |
| 11/4/2022 | KeyCorp | Lower Target | Overweight | $75.00 ➝ $60.00 | |
| 11/4/2022 | Cantor Fitzgerald | Lower Target | | $79.00 ➝ $62.00 | |
| 11/4/2022 | Robert W. Baird | Lower Target | Outperform | $76.00 ➝ $64.00 | |
| 11/4/2022 | Barclays | Lower Target | Overweight | $70.00 ➝ $63.00 | |
| 10/18/2022 | Barclays | Boost Target | Overweight | $66.00 ➝ $70.00 | |
| 8/9/2022 | Barclays | Lower Target | | $66.00 | |
| 8/9/2022 | Robert W. Baird | Lower Target | | $76.00 | |
| 8/4/2022 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $75.00 ➝ $65.00 | |
| 8/3/2022 | Piper Sandler | Lower Target | Overweight | $76.00 ➝ $70.00 | |
| 8/3/2022 | Robert W. Baird | Lower Target | | $110.00 ➝ $76.00 | |
| 8/3/2022 | Barclays | Lower Target | | $79.00 ➝ $66.00 | |
| 7/15/2022 | Piper Sandler | Lower Target | Overweight | $98.00 ➝ $76.00 | |
| 7/14/2022 | Morgan Stanley | Lower Target | Equal Weight | $70.00 ➝ $66.00 | |
| 5/4/2022 | Cantor Fitzgerald | Lower Target | | $99.00 ➝ $80.00 | |
| 5/4/2022 | Barclays | Lower Target | | $91.00 ➝ $79.00 | |
| 4/19/2022 | Barclays | Boost Target | | $73.00 ➝ $91.00 | |
| 4/5/2022 | Cantor Fitzgerald | Initiated Coverage | Overweight | $99.00 | |
| 2/23/2022 | Canaccord Genuity Group | Lower Target | Buy ➝ Buy | $155.00 ➝ $75.00 | |
| 2/23/2022 | Stifel Nicolaus | Lower Target | Buy | $155.00 ➝ $100.00 | |
| 2/23/2022 | Morgan Stanley | Lower Target | Equal Weight | $110.00 ➝ $70.00 | |
| 2/23/2022 | Needham & Company LLC | Lower Target | Buy | $160.00 ➝ $75.00 | |
| 2/23/2022 | Barclays | Lower Target | Overweight | $92.00 ➝ $73.00 | |
| 2/23/2022 | Robert W. Baird | Lower Target | | $165.00 ➝ $110.00 | |
| 2/23/2022 | Piper Sandler | Lower Target | Overweight | $125.00 ➝ $98.00 | |
| 2/18/2022 | Piper Sandler | Reiterated Rating | Buy | $125.00 | |
| 1/12/2022 | Barclays | Lower Target | | $162.00 ➝ $92.00 | |
| 1/12/2022 | Piper Sandler | Lower Target | Overweight | $155.00 ➝ $125.00 | |
| 12/16/2021 | Morgan Stanley | Lower Target | Equal Weight | $146.00 ➝ $110.00 | |
| 9/23/2021 | Needham & Company LLC | Boost Target | Buy | $110.00 ➝ $160.00 | |
| 9/23/2021 | Piper Sandler | Boost Target | Overweight | $104.00 ➝ $155.00 | |
| 9/23/2021 | William Blair | Reiterated Rating | Buy | | |
| 9/20/2021 | KeyCorp | Boost Target | Overweight | $112.00 ➝ $153.00 | |
| 9/20/2021 | BTIG Research | Boost Target | Buy | $110.00 ➝ $150.00 | |
| 9/17/2021 | Barclays | Boost Target | Overweight | $112.00 ➝ $158.00 | |
| 9/7/2021 | Stifel Nicolaus | Boost Target | Buy | $105.00 ➝ $135.00 | |
| 8/4/2021 | Needham & Company LLC | Boost Target | Buy | $100.00 ➝ $110.00 | |
| 8/4/2021 | Piper Sandler | Boost Target | Overweight | $86.00 ➝ $104.00 | |
| 7/23/2021 | Barclays | Boost Target | Positive ➝ Overweight | $77.00 ➝ $106.00 | |
| 7/16/2021 | Needham & Company LLC | Boost Target | Buy | $80.00 ➝ $100.00 | |
| 7/16/2021 | Stifel Nicolaus | Boost Target | Buy | $85.00 ➝ $95.00 | |
| 6/24/2021 | BTIG Research | Boost Target | Buy | $80.00 ➝ $110.00 | |
| 6/18/2021 | Robert W. Baird | Boost Target | Outperform | $85.00 ➝ $93.00 | |
| 6/1/2021 | KeyCorp | Initiated Coverage | Overweight | $82.00 | |